Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Participants With Persistent Asthma

Study Title

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

Teva Identifier

FSS-AS-30017 | 2014-000923-25

ClinicalTrials.gov Identifier

NCT02141854

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: FS MDPI | Drug: Fp MDPI | Drug: Placebo MDPI | Drug: Albuterol/salmeterol HFA MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

06/01/2014 - 09/01/2015

Phase

Phase 3

Study Type

Interventional